高级检索
当前位置: 首页 > 详情页

The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1.

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Chemotherapy, Zhongshan People’s Hospital, Zhongshan, Guangdong 528400, China [2]TCM-Integrated Hospital, Southern Medical University, Cancer Center, NO.13 Shiliugang Road, Haizhu District, Guangzhou, Guangdong 510315, China.
出处:

关键词: miR-325 HMGB1 Proliferation Invasion Hepatocarcinoma carcinoma

摘要:
MicroRNAs (miRNAs) can serve as tumor suppressors and might provide an efficient strategy for annihilating tumor cells. Nevertheless, the potential role of miR-325 in hepatocellular carcinoma (HCC) is still unknown. Using RT-PCR, immunoblots invasion assays and bioinformatics strategies, we investigated the potential role of miR-325 in HCC. We showed that miR-325 was decreased and HMGB1 was increased in 99 patients with hepatocellular carcinoma. MiR-325 inhibition promoted cell invasion and proliferation, while miR-325 upregulation inhibited cell invasion and proliferation by using transwell and CCK8 assays. We further showed that HMGB1 might be a direct target of miR-325 and is negatively regulated by miR-325. Down-regulation of miR-325 predicts poor prognosis for HCC patients. These findings implied that miR-325 regulates cell invasion and proliferation via targeting HMGB1 and may be a potential prognostic marker for HCC. The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/4655707031717989.

语种:
PubmedID:
中科院(CAS)分区:
出版当年[2014]版:
大类 | 4 区 医学
小类 | 4 区 病理学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 病理学
第一作者:
第一作者机构: [1]Department of Chemotherapy, Zhongshan People’s Hospital, Zhongshan, Guangdong 528400, China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号